Tag: alzheimer’s disease (AD)

pathology image of a Lewy body inclusion
February 15, 2024/Brain Health

Lewy Body Pathology Linked to Cerebral Amyloid Angiopathy in Alzheimer’s Disease Patients

Recognizing this association aids risk assessment before starting novel immunotherapies

23-NEU-4390509-CQD-Hero-650×450

Microglial Immunometabolism Endophenotypes Implicated in Sex Differences in Alzheimer’s Disease

Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches

Light trails coming from African American’s head

Blood-Based Biomarkers for Alzheimer’s Disease in Women (Podcast)

Research project aims to pinpoint biomarkers that could speed diagnosis

23-NEU-4216627_researcher-in-lab_650x450

An All-Fronts Approach to Understanding and Overcoming Alzheimer’s Disease

A conversation with Feixiong Cheng, PhD, about his wide-ranging research initiatives

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-NEU-3890310-CQD-Hero-650×450

Does Sleep Dysfunction Help Explain Sex Differences in Alzheimer’s Incidence and Progression?

Novel research is comparing sleep measures to biomarkers of neurodegeneration

23-NEU-3890311_alzheimers-in-women_650x450

Pilot Study to Target Sex-Based Differences in Alzheimer’s Disease

Plasma proteome analysis aimed at identifying candidate blood-based biomarkers in women

23-NEU-3739358-CQD-Hero-650×450
April 13, 2023/Brain Health

Markers of Metabolic Syndrome Linked to Cognitive Decline in MCI and Alzheimer’s

High plasma ApoA1 and TG/HDL-C ratio predict faster progression

22-NEU-3482371 Alzheimers-brain-650×450
January 12, 2023/Brain Health

Does Peripheral Inflammation Drive Alzheimer’s Disease Progression?

New research explores the role of immune cell and blood-brain barrier changes

22-NEU-3452010_AI-in-brain-research_650x450

Deep Learning Framework Unveiled for Identifying Risk Genes and Drug Targets in Alzheimer’s Disease

Open-source artificial intelligence technology uses human genetic data to find candidate drugs

22-NEU-3450073-CQD-Hero-650×450
December 13, 2022/Geriatrics

What’s the State of Anti-Amyloid Therapy in the Wake of Initial Clarity AD Findings?

Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved

BackPage 1 of 3Next
Advertisement
Ad